NM_000257.4:c.556G>C
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_Strong
The NM_000257.4(MYH7):c.556G>C(p.Val186Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 1 Uncertain:1
This MYH7 Val186Leu variant has not previously been described in the literature. We have identified this variant in 1 HCM proband (Ingles J, et al., 2005) and their affected child. The variant is absent in the Genome Aggregation Database (http://gnomad.broadinstitute.org/). In silico models are inconsistent with SIFT and MutationTaster both predicting the change to be "deleterious" and "disease-causing" while PolyPhen-2 predicts the change to be "benign". The rarity of this variant in in the general population, and the results from family screening, suggests MYH7 Val186Leu may be a likely pathogenic candidate. However, the number of family members are too small to completely exclude a benign role. Stronger segregation data and/or other functional evidence is required to establish its role in disease. Thus, we classify this MYH7 Val186Leu variant as one of "uncertain significance". -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at